[MYGN] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
02-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -148.94%
YoY- -242.68%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 183,500 181,200 177,800 156,400 179,300 164,900 160,800 9.22%
PBT -116,100 -52,600 -52,100 -44,200 -17,900 -26,400 -43,500 92.75%
Tax -1,900 2,100 -9,800 -9,100 -3,800 -5,900 -35,900 -85.97%
NP -116,100 -54,700 -42,300 -35,100 -14,100 -20,500 -7,600 518.74%
Tax Rate - - - - - - - -
Total Cost 299,600 235,900 220,100 191,500 193,400 185,400 168,400 46.97%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -63.27 -30.19 -23.79 -22.44 -7.86 -12.43 -4.73 466.17%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 -0.10 489.25%
EPS Diluted -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 -0.10 489.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.